Novonesis and Novo Nordisk expect results by late 2027 from research on whether microbiome supplements can benefit users of GLP-1 weight-loss drugs.
Novonesis has agreed to acquire Meihua Holdings' fermentation facility in Rayong, Thailand, for approximately $50 million to expand its Southeast Asian footprint. The site will support human milk olig
Novonesis forecasts sales growth and margin expansion for 2026, anticipating good Q1 performance following increased Q4 2025 earnings driven by higher sales.
Novonesis has secured renewable electricity for its global operations by 2025, focusing on wind and solar projects to support sustainable manufacturing.
Novonesis and Thyssenkrupp have launched a new enzymatic fat-splitting process to support sustainable fatty acid manufacturing in the oleochemical industry, with a pilot plant planned for scalable imp
Novonesis raised its Q4 organic sales growth guidance to mid-single digits while lowering margin expectations due to currency effects, reporting increased sales in Q3.
ChemBrief